Pharmaceutical - USA, India

Filter

Current filters:

USAIndia

Popular Filters

Wockhardt target for fresh FDA concerns over US unit

Wockhardt target for fresh FDA concerns over US unit

28-05-2014

Indian drugmaker Wockhardt is facing fresh concerns from the US Food and Drug Administration over processes…

Clinical researchHealth Medical PharmaIndiaManaging directorPharmaceuticalPharmaceutical sciencesProductionRegulationUnited StatesUSAWockhardt

USTR expresses growing concerns on IP protection in India and other markets

01-05-2014

The Office of the US Trade Representative (USTR) has released its annual “Special 301” Report on…

CanadaIndiaPatentsPharmaceuticalUSA

India unrelenting over alleged lax IPR; may drag the USA to the WTO

28-04-2014

A clarion call has been sounded by Indian government officials, who are unwilling to buckle under pressure…

Asia-PacificIndiaPatentsPharmaceuticalPoliticsUSA

Pfizer tackles Torrent over generic Viagra

Pfizer tackles Torrent over generic Viagra

19-03-2014

US pharma giant Pfizer is taking legal action against Indian drugmaker Torrent Pharmaceuticals to stop…

GenericsIndiaLegalMen's HealthPfizerPharmaceuticalTorrent PharmaceuticalsUSAViagra

USA and India continue disagreement on IP protection

USA and India continue disagreement on IP protection

17-03-2014

India’s record to uphold intellectual property rights is anything but solid, a major US business group…

IndiaPatentsPharmaceuticalPoliticsUSA

Ranbaxy recalls Lipitor generic over dose error

Ranbaxy recalls Lipitor generic over dose error

10-03-2014

India’s largest drugmaker Ranbaxy Laboratories (BSE: 500359) has recalled more than 64,000 bottles…

Atorvastatin CalciumCardio-vascularIndiaLipitorPharmaceuticalRanbaxy LaboratoriesRegulationUSA

India and the USA need to collaborate

India and the USA need to collaborate

14-02-2014

Here's our take on the week's top stories.

IndiaPharmaceuticalRanbaxy LaboratoriesRegulationUSAWockhardt

US FDA visit to India results in first Statement of Intent

US FDA visit to India results in first Statement of Intent

12-02-2014

A Statement of Intent has been jointly signed by officials at India’s Ministry of Health and Family…

IndiaPharmaceuticalPoliticsRegulationUSA

India raises concerns over FDA action during visit to promote collaboration

India raises concerns over FDA action during visit to promote collaboration

11-02-2014

The US Food and Drug Administration Commissioner Margaret Hamburg has met with India’s Commerce and…

IndiaPharmaceuticalRegulationUSA

Wockhardt drugs from Indian plant banned by US FDA

Wockhardt drugs from Indian plant banned by US FDA

28-11-2013

The US Food and Drug Administration has issued an import alert on medicines made by Indian drugmaker…

IndiaPharmaceuticalRegulationUSAWockhardt

New products will grow atopic dermatitis market to $5.6 billion by 2022

New products will grow atopic dermatitis market to $5.6 billion by 2022

15-11-2013

Atopic dermatitis therapeutic sales in nine major global markets are forecast to increase from $3.9 billion…

Anacor PharmaceuticalsChinaDermatologicalsdupilumabEuropeIndiaMarkets & MarketingPharmaceuticalRegeneronSanofiUSA

Back to top